Skip to content

Charmadent

Active
Private limited company·Activiteiten van tandartspraktijken· 4 yrs active
Begoniastraat 48 ·8310 Brugge, Belgium
KBO/BCE: BE 0774.692.280
Watch Print / PDF
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Charmadent is 0.2% (very low). The 2025 annual accounts show equity of €3k and a net result of €371k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 87 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 87 sector peers (2025).
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-04-2026, 107 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 15-04-2026 107 d early 2026-00079831
31-12-2024 31-07-2025 26-06-2025 35 d early 2025-00178900
31-12-2023 31-07-2024 11-06-2024 50 d early 2024-00120854
31-12-2022 31-07-2023 21-07-2023 10 d early 2023-00257959

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2021, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€371k+62.4%
Working capital€-38k

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 15-04-2026 with the NBB · fiscal year 2025 · verkort
€0€200k€400kOperating result 2022: €280k€280kNet result 2022: €213k€213kOperating result 2023: €404k€404kNet result 2023: €306k€306kOperating result 2024: €299k€299kNet result 2024: €229k€229kOperating result 2025: €472k€472kNet result 2025: €371k€371k2022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~51% of the level (threshold 35%). We therefore deliberately show no projection line.
€0€200k€400k€600k€800k2022: €215k2023: €520k2024: €749k2025: €3k2022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 0.6% 56.8%
better than 5% of 87 sector peers
Net result €371k €97k
better than 86% of 87 sector peers
Equity €3k €207k
better than 5% of 87 sector peers
Gross operating margin €485k €237k
better than 71% of 84 sector peers
Total assets €389k €591k
better than 41% of 87 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P5
2022: P79 · n=2602023: P93 · n=3452024: P95 · n=3822025: P5 · n=872022 2025
Weakening position over 2022-2025 · n=87-382
Net result P86
2022: P81 · n=2562023: P86 · n=3392024: P78 · n=3722025: P86 · n=872022 2025
Stable position over 2022-2025 · n=87-372
Equity P5
2022: P64 · n=2602023: P76 · n=3452024: P83 · n=3822025: P5 · n=872022 2025
Weakening position over 2022-2025 · n=87-382
Gross operating margin P71
2022: P67 · n=2532023: P74 · n=3342024: P62 · n=3722025: P71 · n=842022 2025
Stable position over 2022-2025 · n=84-372
Describes the position versus peers, not a forecast.
EBITDA
€485k
+58.6% 22-25
Net profit
€371k
+62.4% 22-25
Cash flow
€384k
+63.2% 22-25
Total assets
€389k
-49.9% 22-25
Equity
€3k
-99.7% 22-25
Working capital
€-38k
- 22-25
Staff costs
€2k
- 22-25
Income taxes
€116k
+61.9% 22-25
Dividends
€1.12M
+134047.9% 22-25
Debt
€387k
+1316.6% 22-25
Debt ≤ 1y
€377k
+1280.0% 22-25
Debt > 1y
€10k
- 22-25
Current ratio
0.90
-96.8% 22-25
Quick ratio
0.90
-96.8% 22-25
Solvency
0.6%
-99.3% 22-25
Debt / equity
154.61
+424073.2% 22-25
ROE
14855.5%
+48533.0% 22-25
ROA
95.5%
+223.9% 22-25
Interest coverage
10781.79
+54.4% 22-25
Figures by fiscal year
Fiscal year2025
Depositverkort
Revenue-
EBITDA€485k
Net profit€371k
Cash flow€384k
Staff costs-
Income taxes€116k
Dividends€1.12M
Total assets€389k
Equity€3k
Debt€387k
of which ≤ 1y€377k
of which > 1y€10k
Working capital€-38k
Employees (FTE)-
Ratios (computed)
2025
Current ratio0.90
Quick ratio0.90
Working capital ratio-9.9%
Solvency0.6%
Debt / equity154.61
Long-term debt ratio4.00
Interest coverage10781.79
Gross margin-
Net margin-
ROA95.5%
ROE14855.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€389k
Fixed assets 21/28€51k
Tangible fixed assets 22/27€51k
Current assets 29/58€338k
Amounts receivable within one year 40/41€29k
Cash & bank 54/58€291k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€389k
Equity 10/15€3k
Contributions / capital 10/11€3k
Amounts payable 17/49€387k
Amounts payable after one year 17€10k
Amounts payable within one year 42/48€377k
Trade debts payable within one year 44€4k
Income statement
Gross operating margin 9900€485k
Operating result 9901€472k
Financial income 75€15k
Financial charges 65€45
Result before taxes 9903€487k
Income taxes 67/77€116k
Net result for the period 9904€371k
Result to be appropriated 9905€371k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
53 / 100 Fair
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Begoniastraat 488310 Brugge

Establishment units

1 location
Charmadent
Begoniastraat 48, 8310 BruggeActiviteiten van tandartspraktijken
since 20212.322.577.896
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area354 m²
Buildings1
Building footprint100 m²
Volume (LiDAR)17 m³
Tallest building7.7 m

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31434C0019/00S002 Flanders 354 m² 1 · 100 m² 7.7 m
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

No structured acts for this company yet

That means one of two things: the company has published no company deeds, or its deeds are still queued for reading. The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Snowflake analysis

financial profile on 5 axes
Health53Profitability100Solvency9Growth58Stability94
63 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 53
Profitability 100
Solvency 9
Growth 58
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230Overige vormen van onderwijs85599Overige vormen van onderwijs85599Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995
Primary activity highlighted.
Names & trade names
Legal nameNL Charmadent
Registered office
Begoniastraat 48
8310 Brugge, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.